Matches in SemOpenAlex for { <https://semopenalex.org/work/W3048607213> ?p ?o ?g. }
- W3048607213 endingPage "3060" @default.
- W3048607213 startingPage "3048" @default.
- W3048607213 abstract "Metronomic chemotherapy refers to the minimum biologically effective doses of a chemotherapy agent given as a continuous regimen without extended rest periods. Drug repurposing is defined as the use of an already known drug for a new medical indication, different from the original one. In oncology the combination of these two therapeutic approaches is called Metronomics. The aim of this work is to evaluate the therapeutic effect of cyclophosphamide in a metronomic schedule in combination with the repurposed drug losartan in two genetically different mice models of triple negative breast cancer. Our findings showed that adding losartan to metronomic cyclophosphamide significantly improved the therapeutic outcome. In both models the combined treatment increased the mice's survival without sings of toxicity. Moreover, we elucidated some of the mechanisms of action involved, which include a decrease of intratumor hypoxia, stimulation of the immune response and remodeling of the tumor microenvironment. The remarkable therapeutic effect, the lack of toxicity, the low cost of the drugs and its oral administration, strongly suggest its translation to the clinical setting in the near future." @default.
- W3048607213 created "2020-08-18" @default.
- W3048607213 creator A5002356390 @default.
- W3048607213 creator A5005300802 @default.
- W3048607213 creator A5006016730 @default.
- W3048607213 creator A5018882770 @default.
- W3048607213 creator A5026376296 @default.
- W3048607213 creator A5063223752 @default.
- W3048607213 creator A5067138856 @default.
- W3048607213 creator A5075981294 @default.
- W3048607213 creator A5080410227 @default.
- W3048607213 creator A5082008949 @default.
- W3048607213 creator A5087622321 @default.
- W3048607213 date "2020-08-11" @default.
- W3048607213 modified "2023-09-27" @default.
- W3048607213 title "Losartan improves the therapeutic effect of metronomic cyclophosphamide in triple negative mammary cancer models" @default.
- W3048607213 cites W1540583520 @default.
- W3048607213 cites W1865147832 @default.
- W3048607213 cites W1897802257 @default.
- W3048607213 cites W1929987490 @default.
- W3048607213 cites W1943173994 @default.
- W3048607213 cites W1973091654 @default.
- W3048607213 cites W1978494029 @default.
- W3048607213 cites W1982852026 @default.
- W3048607213 cites W1987283016 @default.
- W3048607213 cites W1999870241 @default.
- W3048607213 cites W2003787288 @default.
- W3048607213 cites W2029883816 @default.
- W3048607213 cites W2034548257 @default.
- W3048607213 cites W2037609753 @default.
- W3048607213 cites W2039177386 @default.
- W3048607213 cites W2052753304 @default.
- W3048607213 cites W2055410643 @default.
- W3048607213 cites W2059294866 @default.
- W3048607213 cites W2080250619 @default.
- W3048607213 cites W2098054841 @default.
- W3048607213 cites W2098464561 @default.
- W3048607213 cites W2100934193 @default.
- W3048607213 cites W2106573979 @default.
- W3048607213 cites W2108018907 @default.
- W3048607213 cites W2109090266 @default.
- W3048607213 cites W2114592067 @default.
- W3048607213 cites W2131475382 @default.
- W3048607213 cites W2137816700 @default.
- W3048607213 cites W2138652650 @default.
- W3048607213 cites W2152350731 @default.
- W3048607213 cites W2169965478 @default.
- W3048607213 cites W2169992085 @default.
- W3048607213 cites W2303436115 @default.
- W3048607213 cites W2419602338 @default.
- W3048607213 cites W2428037116 @default.
- W3048607213 cites W2508661034 @default.
- W3048607213 cites W2530522266 @default.
- W3048607213 cites W2531169769 @default.
- W3048607213 cites W2559365457 @default.
- W3048607213 cites W2586781596 @default.
- W3048607213 cites W2589308094 @default.
- W3048607213 cites W2607025554 @default.
- W3048607213 cites W2889646458 @default.
- W3048607213 cites W2909932177 @default.
- W3048607213 doi "https://doi.org/10.18632/oncotarget.27694" @default.
- W3048607213 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7429183" @default.
- W3048607213 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32850009" @default.
- W3048607213 hasPublicationYear "2020" @default.
- W3048607213 type Work @default.
- W3048607213 sameAs 3048607213 @default.
- W3048607213 citedByCount "4" @default.
- W3048607213 countsByYear W30486072132021 @default.
- W3048607213 countsByYear W30486072132022 @default.
- W3048607213 crossrefType "journal-article" @default.
- W3048607213 hasAuthorship W3048607213A5002356390 @default.
- W3048607213 hasAuthorship W3048607213A5005300802 @default.
- W3048607213 hasAuthorship W3048607213A5006016730 @default.
- W3048607213 hasAuthorship W3048607213A5018882770 @default.
- W3048607213 hasAuthorship W3048607213A5026376296 @default.
- W3048607213 hasAuthorship W3048607213A5063223752 @default.
- W3048607213 hasAuthorship W3048607213A5067138856 @default.
- W3048607213 hasAuthorship W3048607213A5075981294 @default.
- W3048607213 hasAuthorship W3048607213A5080410227 @default.
- W3048607213 hasAuthorship W3048607213A5082008949 @default.
- W3048607213 hasAuthorship W3048607213A5087622321 @default.
- W3048607213 hasBestOaLocation W30486072131 @default.
- W3048607213 hasConcept C102652120 @default.
- W3048607213 hasConcept C121608353 @default.
- W3048607213 hasConcept C126322002 @default.
- W3048607213 hasConcept C143998085 @default.
- W3048607213 hasConcept C170493617 @default.
- W3048607213 hasConcept C2776694085 @default.
- W3048607213 hasConcept C2776755627 @default.
- W3048607213 hasConcept C2780035454 @default.
- W3048607213 hasConcept C2780288358 @default.
- W3048607213 hasConcept C2908929049 @default.
- W3048607213 hasConcept C530470458 @default.
- W3048607213 hasConcept C71924100 @default.
- W3048607213 hasConcept C98274493 @default.
- W3048607213 hasConceptScore W3048607213C102652120 @default.
- W3048607213 hasConceptScore W3048607213C121608353 @default.
- W3048607213 hasConceptScore W3048607213C126322002 @default.